CJ
GILD icon

Caitlin John’s Gilead Sciences GILD Stock Holding History

Caitlin John’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.4K Buy
351
+2
+0.6% +$264 0.02% 382
2026
Q1 		$48.6K Sell
349
-98
-22% -$13.7K 0.03% 314
2025
Q4 		$54.9K Buy
447
+102
+30% +$12.4K 0.04% 297
2025
Q3 		$38.3K Buy
+345
New +$39.2K 0.03% 304
2025
Q1 		– Sell
-338
Closed -$31.2K – 380
2024
Q4 		$31.2K Buy
338
+3
+0.9% +$270 0.02% 303
2024
Q3 		$31.1K Buy
335
+3
+0.9% +$229 0.02% 309
2024
Q2 		$22.8K Sell
332
-5
-1% -$334 0.02% 343
2024
Q1 		$24.7K Buy
337
+2
+0.6% +$154 0.02% 332
2023
Q4 		$27.1K Buy
+335
New +$26.1K 0.02% 297

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Caitlin John's GILD Position: Q2 2026 in Review

Caitlin John increased its Gilead Sciences (GILD) stake by 0.57% in Q2 2026, buying an estimated $264 and bringing the position to 351 shares worth $44.4K. The position accounts for 0.02% of the portfolio, ranked #382.

Caitlin John first reported a position in GILD in Q4 2023 and has held it in 9 quarters since. The position peaked at $54.9K in Q4 2025. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Caitlin John held 351 shares of Gilead Sciences worth $44.4K as of Q2 2026.
  • Caitlin John bought 2 Gilead Sciences shares in Q2 2026, an estimated $264.
  • Gilead Sciences made up 0.02% of Caitlin John's portfolio in Q2 2026, its #382 holding.
  • Caitlin John first reported a position in Gilead Sciences in Q4 2023 and has held it in 9 quarters since.
  • Caitlin John's Gilead Sciences position peaked at $54.9K in Q4 2025.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Caitlin John's 13F filing for Q2 2026, filed 17 Aug 2026.